447 related articles for article (PubMed ID: 28637906)
1. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Werner RN; Westfechtel L; Dressler C; Nast A
Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod for anogenital warts in non-immunocompromised adults.
Grillo-Ardila CF; Angel-Müller E; Salazar-Díaz LC; Gaitán HG; Ruiz-Parra AI; Lethaby A
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010389. PubMed ID: 25362229
[TBL] [Abstract][Full Text] [Related]
3. Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis.
Werner RN; Westfechtel L; Dressler C; Nast A
Sex Transm Infect; 2017 May; 93(3):155-161. PubMed ID: 27803240
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis.
Westfechtel L; Werner RN; Dressler C; Gaskins M; Nast A
Sex Transm Infect; 2018 Feb; 94(1):21-29. PubMed ID: 28819018
[TBL] [Abstract][Full Text] [Related]
9. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
Schöfer H; Tatti S; Lynde CW; Skerlev M; Hercogová J; Rotaru M; Ballesteros J; Calzavara-Pinton P
Int J STD AIDS; 2017 Dec; 28(14):1433-1443. PubMed ID: 28566057
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
[TBL] [Abstract][Full Text] [Related]
11. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
12. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
[TBL] [Abstract][Full Text] [Related]
13. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of anogenital warts with topical cidofovir].
Fernández-Morano T; Del Boz J; Frieyro-Elichegui M; Repiso JB; Padilla-España L; de Troya-Martín M
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):222-6. PubMed ID: 23182242
[TBL] [Abstract][Full Text] [Related]
15. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
Schöfer H
Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis.
Tejada RA; Vargas KG; Benites-Zapata V; Mezones-Holguín E; Bolaños-Díaz R; Hernandez AV
Salud Publica Mex; 2017; 59(1):84-94. PubMed ID: 28423114
[TBL] [Abstract][Full Text] [Related]
18. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
[TBL] [Abstract][Full Text] [Related]
19. High-grade Dysplasia in Anogenital Warts of HIV-Positive Men.
Kreuter A; Siorokos C; Oellig F; Silling S; Pfister H; Wieland U
JAMA Dermatol; 2016 Nov; 152(11):1225-1230. PubMed ID: 27463201
[TBL] [Abstract][Full Text] [Related]
20. Cryotherapy to treat anogenital warts in nonimmunocompromised adults: Systematic review and meta-analysis.
Bertolotti A; Dupin N; Bouscarat F; Milpied B; Derancourt C
J Am Acad Dermatol; 2017 Sep; 77(3):518-526. PubMed ID: 28651824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
